Friday, 29 January 2021

UK vaccine strategy 'paying off' as latest trials boost stockpiles

Pre-ordering of Janssen and Novavax means Britain has procured 247m successfully trialled jabs * Coronavirus – latest updates * See all our coronavirus coverage Britain has cemented its status as one of the world’s leading buyers of effective Covid vaccines after two more pharmaceutical companies reported positive trial results – potentially growing the UK stockpile by 90m doses. The US drugmaker Johnson & Johnson announced on Friday that its vaccine – which requires only one dose – is effective. This followed Thursday’s news that the Novavax vaccine, which will be manufactured in the UK, performed well in phase 3 trials. Continue reading...
http://dlvr.it/RrdNqf
at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Chuka

By  Chimamanda Ngozi Adichie ,  Fiction , THE NEW YORKER  February 10, 2025 Photograph by Nakeya Brown for The New Yorker I have always long...

  • The Universal Drink
    The making—and selling—of Coca-Cola. By  E. J. Kahn, Jr. , THE NEW YORKER,  Profiles February 6, 1959 Photograph by George Marks / Retrofile...
  • The Moment Sarah Palin’s Testimony Fell Apart
    At the New York Times trial, the former governor was impressive at first. It didn’t last. BY  SETH STEVENSON  |  Slate FEB 10, 20228:31 PM S...